ABSTRACT-Since neuropeptide FF (NPFF) is a putative neurotransmitter to exert anti-opioid activity, we examined the effects of [D-Tyr 1 , (NMe)Phe
3]neuropeptide FF (1DMe), a stable NPFF analog, on acetylcholine (ACh) release from a longitudinal muscle-myenteric plexus (LMMP) preparation of guinea pig ileum in which opioids were known to inhibit ACh release when muscarinic autoinhibition was not fully activated. In the presence of atropine, 1DMe increased spontaneous and electrical field stimulation (EFS)-evoked ACh release in a concentration-dependent manner. Naloxone also increased ACh release. The stimulatory effects of 1DMe and naloxone were not additive. In the absence of atropine, 1DMe did not affect ACh release. Morphine decreased spontaneous and EFS-evoked ACh release in the presence of 1 mM atropine. 1DMe as well as naloxone counteracted the inhibitory effects of morphine on EFS-evoked ACh release. The combination of 1DMe and naloxone was not more inhibitory than either drug alone. 1DMe had no appreciable effect on norepinephrine-induced inhibition of spontaneous and EFS-evoked ACh release. These results first demonstrated the effects of a NPFF analog on neurotransmitter release: 1DMe had a stimulatory effect on spontaneous and EFS-induced ACh release from the LMMP preparation of guinea pig ileum, probably by counteracting the inhibitory effect of endogenous opioids on ACh release.Keywords: Neuropeptide FF, Acetylcholine release, Morphine, Muscarinic autoinhibition, Myenteric plexusThe important role of an octapeptide neuropeptide FF (Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH 2; NPFF) has been demonstrated in the central nervous system (1). NPFF exerts modulatory action on morphine-induced analgesia in rodents (2, 3). Namely, the intracerebroventricular administration of NPFF reverses morphine-induced analgesia in rats (1). NPFF antagonizes the modulation of Ca 2+ channels by mu-opioids in isolated rat spinal ganglion and dorsal raphe neurons (4, 5) and by nociceptin in rat dorsal raphe neurons (5). NPFF modulates the excitatory synaptic transmission through an interaction with presynaptic delta-opioid receptors in the pontine parabrachial nucleus in vitro (6). Although these results suggest that NPFF reverses the effect of morphine or endogenous opioids, the exact mechanism of the action of NPFF at the neuronal and cellular level remains unknown.It is well known that morphine has a marked inhibitory effect on the motility of the gastrointestinal tract in the human as well as experimental animals (7). The inhibitory effect of morphine is mainly due to reduction in acetylcholine (ACh) release from enteric cholinergic neurons (8, 9). In a previous report, we demonstrated that morphine inhibited ACh release from longitudinal muscle with myenteric plexus (LMMP) preparations of the guinea pig ileum when muscarinic autoinhibition was not fully activated (10). We also demonstrated that endogenous opioids are involved in the regulation of ACh release, because naloxone increases electrical field stimulation (EFS)-evoke...